Health disparities in urologic oncology, particularly in prostate, bladder, kidney, and testicular cancers, significantly impact patient outcomes across different demographic groups. This narrative review aims to investigate the extent and drivers of these disparities, focusing on the influence of race, socioeconomic status, and geographic location on diagnosis, treatment, and survival outcomes. We conducted a comprehensive review of the existing literature and analyzed data from national cancer databases to identify patterns of inequity. Our findings reveal that minority populations, individuals with lower socioeconomic status, and those residing in underserved areas are less likely to receive timely and guideline-based care, leading to worse outcomes. This review underscores the urgent need for targeted interventions, including policy reforms, health system restructuring, enhanced community outreach, and increased funding for disparity-focused research, to ensure equitable access to high-quality oncologic care. Addressing these disparities is crucial for improving cancer outcomes and achieving health equity in urologic oncology.
泌尿系统肿瘤（尤其是前列腺癌、膀胱癌、肾癌和睾丸癌）领域的健康差异在不同人口群体中对患者预后产生显著影响。本文通过叙述性综述，旨在探究这些差异的程度及其驱动因素，重点关注种族、社会经济地位和地理位置对诊断、治疗及生存结局的影响。我们系统梳理了现有文献，并基于国家癌症数据库的数据进行分析，以揭示医疗不平等的模式。研究发现，少数族裔群体、社会经济地位较低的个体以及医疗服务不足地区的居民，往往更难获得及时且符合指南规范的诊疗，从而导致更差的临床结局。本综述强调亟需采取针对性干预措施，包括政策改革、卫生体系重构、加强社区健康服务以及增加针对健康差异研究的资金投入，以确保所有人群都能公平获得高质量的肿瘤诊疗服务。解决这些差异对于改善癌症预后、实现泌尿系统肿瘤领域的健康公平至关重要。
Striving for Equity: Examining Health Disparities in Urologic Oncology
肿瘤(癌症)患者之家